Trademark: 90503585
Status Date
Monday, July 3, 2023
Filing Date
Tuesday, February 2, 2021
Published for Opposition
Tuesday, April 5, 2022
Abandoned Date
Monday, July 3, 2023
5 Pharmaceutical preparations of stem cells derived from umbilical cord blood and expanded in culture for use in stem cell transplantation and regenerative therapy, in medical or clinical use
Jul 3, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 3, 2023
Abandonment - No Use Statement Filed
Oct 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 27, 2022
Sou Extension 1 Granted
Oct 27, 2022
Sou Extension 1 Filed
Oct 27, 2022
Teas Extension Received
May 31, 2022
Noa E-Mailed - Sou Required From Applicant
Apr 5, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 5, 2022
Published For Opposition
Mar 16, 2022
Notification Of Notice Of Publication E-Mailed
Mar 3, 2022
Approved For Pub - Principal Register
Feb 28, 2022
Teas/Email Correspondence Entered
Feb 28, 2022
Correspondence Received In Law Office
Feb 28, 2022
Teas Response To Office Action Received
Feb 15, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 15, 2022
Teas Change Of Correspondence Received
Feb 15, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 15, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 15, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 15, 2022
Teas Change Of Owner Address Received
Sep 3, 2021
Notification Of Non-Final Action E-Mailed
Sep 3, 2021
Non-Final Action E-Mailed
Sep 3, 2021
Non-Final Action Written
Aug 24, 2021
Assigned To Examiner
May 5, 2021
New Application Office Supplied Data Entered
Feb 5, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
